HST.977 Critical Reading and Technical Assessment of Biomedical Information


Class Info

Gain experience in critical reading of scientific literature, including patents, journal articles and FDA labels, with an emphasis on analyzing clinical controversies and emerging technologies in subject areas that have been or could become sources of entrepreneurial activity. Students required to analyze a variety of topics in the scientific literature, including screening for and cost-effectiveness of early detection of cancer, therapeutic opportunities in oncology, evaluation of immunotoxins and antibody therapies, and new prospects for the treatment of autoimmune disorders. To support the discussion of these topics, outside experts may be invited to participate as facilitators.

This class has no prerequisites.

HST.977 will not be offered this semester. It will be available in the Spring semester, and will be instructed by S. Lapidus and J. Karp.

Lecture occurs 6:30 PM to 8:30 PM on Mondays in E25-101.

This class counts for a total of 3 credits.

In the Spring 2016 Half Term Subject Evaluations, HST.977 was rated 7.0 out of 7.0. You can find more information at the Health Sciences and Technology (HST) < MIT site or on the HST.977 Stellar site.

MIT HST.977 Critical Reading and Technical Assessment of Biomedical Information Related Textbooks
MIT HST.977 Critical Reading and Technical Assessment of Biomedical Information On The Web
Health Sciences and Technology (HST) &lt; MIT
Tags
subject hst instructor prereq acad l. g. celi v. nikore

© Copyright 2015